The North America Veterinary Vaccines Market should witness market growth of 5.1% CAGR during the forecast period (2023-2029).
Veterinary vaccines prevent numerous livestock diseases from spreading, thereby safeguarding both animal and human health. Animals are the source of food, meat, protein, milk, and other industrial products like leather and wool. Vaccinations against rabies, foot-and-mouth disease, and the equine influenza virus are some of the most popular veterinary vaccines that work by replicating naturally acquired immunity to stop the spread of infectious pathogens.
Due to several important circumstances, animals and humans are now inextricably intertwined and interdependent. For humans, animals are necessary to sustain life, but animals are at risk for sickness because of a variety of internal and environmental causes, such as disease-causing substances. The injection of veterinary vaccines is one of the most important methods for preventing animal infections. These items stimulate animals' defense mechanisms and prime their immune systems to combat numerous pathogens and future infectious disorders.
Built on recent expansion and vertical integration, it is anticipated that the poultry and egg sectors will continue to experience production growth in 2022. Mexico ended 2021 with a consistent increase in the production of chicken and eggs. Due to its cheaper affordability and variety in Mexican cuisine, chicken meat remains the favored animal protein for household consumption and Mexico is also the world's largest consumer of eggs. Thus, to maintain animal health and prevent hazardous diseases in livestock, the rising production rate of meat and other animal-based products and the high need to ensure food safety is anticipated to raise the use of veterinary vaccines, boosting market expansion in North America.
The US market dominated the North America Veterinary Vaccines Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $2,403.8 million by 2029. The Canada market is poised to grow at a CAGR of 7.5% during (2023-2029). Additionally, The Mexico market should witness a CAGR of 6.6% during (2023-2029).
Based on Route of Administration, the market is segmented into Injection Vaccines, Oral Vaccines and Intranasal/Spray Vaccines. Based on Type, the market is segmented into Livestock Vaccines, Porcine Vaccines, Companion Animal Vaccines, Poultry Vaccines, Aquaculture Vaccines and Others. Based on Technology, the market is segmented into Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines and Others. Based on Distribution Channel, the market is segmented into Veterinary Hospitals, Veterinary Clinics and Retail Pharmacies. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zoetis, Inc., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health, Inc., Virbac, Ceva Santé Animale, Neogen Corporation, Intas Pharmaceuticals Ltd. and Laboratoire LCV.
Veterinary vaccines prevent numerous livestock diseases from spreading, thereby safeguarding both animal and human health. Animals are the source of food, meat, protein, milk, and other industrial products like leather and wool. Vaccinations against rabies, foot-and-mouth disease, and the equine influenza virus are some of the most popular veterinary vaccines that work by replicating naturally acquired immunity to stop the spread of infectious pathogens.
Due to several important circumstances, animals and humans are now inextricably intertwined and interdependent. For humans, animals are necessary to sustain life, but animals are at risk for sickness because of a variety of internal and environmental causes, such as disease-causing substances. The injection of veterinary vaccines is one of the most important methods for preventing animal infections. These items stimulate animals' defense mechanisms and prime their immune systems to combat numerous pathogens and future infectious disorders.
Built on recent expansion and vertical integration, it is anticipated that the poultry and egg sectors will continue to experience production growth in 2022. Mexico ended 2021 with a consistent increase in the production of chicken and eggs. Due to its cheaper affordability and variety in Mexican cuisine, chicken meat remains the favored animal protein for household consumption and Mexico is also the world's largest consumer of eggs. Thus, to maintain animal health and prevent hazardous diseases in livestock, the rising production rate of meat and other animal-based products and the high need to ensure food safety is anticipated to raise the use of veterinary vaccines, boosting market expansion in North America.
The US market dominated the North America Veterinary Vaccines Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $2,403.8 million by 2029. The Canada market is poised to grow at a CAGR of 7.5% during (2023-2029). Additionally, The Mexico market should witness a CAGR of 6.6% during (2023-2029).
Based on Route of Administration, the market is segmented into Injection Vaccines, Oral Vaccines and Intranasal/Spray Vaccines. Based on Type, the market is segmented into Livestock Vaccines, Porcine Vaccines, Companion Animal Vaccines, Poultry Vaccines, Aquaculture Vaccines and Others. Based on Technology, the market is segmented into Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines and Others. Based on Distribution Channel, the market is segmented into Veterinary Hospitals, Veterinary Clinics and Retail Pharmacies. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zoetis, Inc., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health, Inc., Virbac, Ceva Santé Animale, Neogen Corporation, Intas Pharmaceuticals Ltd. and Laboratoire LCV.
Scope of the Study
By Route of Administration
- Injection Vaccines
- Oral Vaccines
- Intranasal/Spray Vaccines
By Type
- Livestock Vaccines
- Porcine Vaccines
- Companion Animal Vaccines
- Poultry Vaccines
- Aquaculture Vaccines
- Others
By Technology
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Others
By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Retail Pharmacies
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Zoetis, Inc.
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Elanco Animal Health, Inc.
- Virbac
- Ceva Santé Animale
- Neogen Corporation
- Intas Pharmaceuticals Ltd.
- Laboratoire LCV
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. North America Veterinary Vaccines Market by Route of Administration
Chapter 5. North America Veterinary Vaccines Market by Type
Chapter 6. North America Veterinary Vaccines Market by Technology
Chapter 7. North America Veterinary Vaccines Market by Distribution Channel
Chapter 8. North America Veterinary Vaccines Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Zoetis, Inc.
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Elanco Animal Health, Inc.
- Virbac
- Ceva Santé Animale
- Neogen Corporation
- Intas Pharmaceuticals Ltd.
- Laboratoire LCV
Methodology
LOADING...
